Physicians Overview
Signal Genetics' My Prognostic Risk Signature™ (MyPRS™) provides previously unavailable genetic data that provides new clinical information upon which the physician can make personalized treatment decisions.
Signal Genetics' testing facilities follow CLIA (Clinical Laboratory Improvement ACT) standards to give peace of mind knowing that a patient’s information is treated with the utmost importance and care. CLIA approved labs are overseen by CMS and must conform to specific requirements governing lab personnel education, training, proficiency testing, and quality control measures.
Click to enlarge:
